Practice · Dosing & titration · continued

Holding a dose indefinitely: is there a documented downside? posts 31–33

Practice › Dosing & titration dose reduction missed dose semaglutide

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

np_gilmoreTL3Nurse practitioner21 Jul 2025#31

If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure.

Written from notes rather than memory, which is why the numbers are specific.

0 likes 12mo

no.silvaTL227 Jul 2025#32

If someone has run holding a dose properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.

27 likes 12mo

m.dalgaardTL3Regular3 Aug 2025#33

b.restrepo, post #21: The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower. The claim… Go to post

Post #31 describes the usual case. This is about the unusual one.

Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt at the step.

If that reads as pedantic, it is, and it has saved me twice.

8 likes in reply to #21 12mo

This topic was referenced in

Coming back to: Where the four-week escalation interval comes from, and what it is notPractice › Dosing & titration · 48 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Revisiting: The arithmetic of an intermediate dose between two label steps Practice › Dosing & titration titration worked example dose reduction tirzepatide Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…	+41	45	808	2mo
[2026 update] Dose numbers across compounds are not on the same scale Practice › Dosing & titration dose reduction worked example semaglutide titration On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…	+14	18	1.2k	13mo
Where the four-week escalation interval comes from, and what it is not Practice › Dosing & titration missed dose semaglutide tirzepatide titration Solved On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. Working notes on four-week escalation interval rather than a…	+56	60	21k	2y
Coming back to: Where the four-week escalation interval comes from, and what it is not Practice › Dosing & titration dose reduction semaglutide titration tirzepatide Solved Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. Four-week escalation interval — I have the…	+44	48	11k	1d
Why "dose equivalence" between different incretin analogues is a weak concept Practice › Dosing & titration tirzepatide dose reduction titration semaglutide Solved Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…	+124	133	11k	5mo

Related topics — sharing the tags dose reduction, missed dose, semaglutide

Topic	Participants	Replies	Views	Activity
[2026 update] Dose numbers across compounds are not on the same scale Practice › Dosing & titration dose reduction worked example semaglutide titration On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…	+14	18	1.2k	13mo
Reaching a dose and staying there for a year: a longitudinal note Practice › Dosing & titration worked example tirzepatide titration semaglutide Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…		2	763	15mo
Amylin receptor signalling and satiety Pharmacology › Receptor biology tirzepatide semaglutide amylin analogues Wiki Amylin receptor signalling and satiety Writing it up because I had to work it out twice and would rather nobody else did. Asking about amylin receptor signalling and satiety directly, because I have read four…	+22	26	1.8k	9mo
How the published trials escalated, tabulated side by side — does this still hold? Practice › Dosing & titration dose reduction tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? Asking about published trials escalated directly, because I have…		2	8.9k	9mo
Drawing from a pen cartridge with a syringe: how the risk profile changes Devices › Pens & autoinjectors subcutaneous injection dead volume missed dose Posting this under the heading it deserves: Drawing from a pen cartridge with a syringe: how the risk profile changes Everything below is what sits behind that. Question about a metering device rather than…		2	159	19mo